ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial

BACKGROUND: The CAO/ARO/AIO-94 demonstrated that neoadjuvant chemoradiotherapy (CRT) could decrease the rate of local recurrence rather than distal metastases in advanced rectal cancer. Adjuvant chemotherapy (ACT) can eliminate micrometastasis, and render a better prognosis to rectal cancer. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingguo, Luo, Dakui, Zhu, Ji, Yang, Lifeng, Liu, Qi, Ma, Yanlei, Liang, Lei, Cai, Sanjun, Zhang, Zhen, Li, Xinxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858777/
https://www.ncbi.nlm.nih.gov/pubmed/31729964
http://dx.doi.org/10.1186/s12885-019-6289-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858777/
https://www.ncbi.nlm.nih.gov/pubmed/31729964
http://dx.doi.org/10.1186/s12885-019-6289-6

Ejemplares similares